Literature DB >> 25525117

A novel immunoregulatory role for NK-cell cytotoxicity in protection from HLH-like immunopathology in mice.

Fernando E Sepulveda1, Sophia Maschalidi1, Christian A J Vosshenrich2, Alexandrine Garrigue1, Mathieu Kurowska1, Gael Ménasche1, Alain Fischer3, James P Di Santo2, Geneviève de Saint Basile4.   

Abstract

The impairment of cytotoxic activity of lymphocytes disturbs immune surveillance and leads to the development of hemophagocytic lymphohistiocytic syndrome (HLH). Although cytotoxic T lymphocyte (CTL) control of HLH development is well documented, the role for natural killer (NK)-cell effector functions in the pathogenesis of this immune disorder remains unclear. In this study, we specifically targeted a defect in cytotoxicity to either CTL or NK cells in mice so as to dissect the contribution of these lymphocyte subsets to HLH-like disease severity after lymphocytic choriomeningitis virus (LCMV) infection. We found that NK-cell cytotoxicity was sufficient to protect mice from the fatal outcome that characterizes HLH-like disease and was also sufficient to reduce HLH-like manifestations. Mechanistically, NK-cell cytotoxicity reduced tissue infiltration by inflammatory macrophages and downmodulated LCMV-specific T-cell responses by limiting hyperactivation of CTL. Interestingly, the critical protective effect of NK cells on HLH was independent of interferon-γ secretion and changes in viral load. Therefore our findings identify a crucial role of NK-cell cytotoxicity in limiting HLH-like immunopathology, highlighting the important role of NK cytotoxic activity in immune homeostasis.
© 2015 by The American Society of Hematology.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25525117     DOI: 10.1182/blood-2014-09-602946

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  24 in total

1.  Functional and genetic testing in adults with HLH reveals an inflammatory profile rather than a cytotoxicity defect.

Authors:  Julien Carvelli; Christelle Piperoglou; Catherine Farnarier; Frédéric Vely; Karin Mazodier; Sandra Audonnet; Patrick Nitschke; Christine Bole-Feysot; Mohamed Boucekine; Audrey Cambon; Mohamed Hamidou; Jean-Robert Harle; Geneviève de Saint Basile; Gilles Kaplanski
Journal:  Blood       Date:  2020-07-30       Impact factor: 22.113

2.  Hemophagocytic Lymphohistiocytosis as a Complication in Patients with MSMD.

Authors:  Rodolfo Muriel-Vizcaino; Marco Yamazaki-Nakashimada; Gabriela López-Herrera; Leopoldo Santos-Argumedo; Noé Ramírez-Alejo
Journal:  J Clin Immunol       Date:  2016-05-04       Impact factor: 8.317

3.  A CD57+ CTL Degranulation Assay Effectively Identifies Familial Hemophagocytic Lymphohistiocytosis Type 3 Patients.

Authors:  Masayuki Hori; Takahiro Yasumi; Saeko Shimodera; Hirofumi Shibata; Eitaro Hiejima; Hirotsugu Oda; Kazushi Izawa; Tomoki Kawai; Masataka Ishimura; Naoko Nakano; Ryutaro Shirakawa; Ryuta Nishikomori; Hidetoshi Takada; Satoshi Morita; Hisanori Horiuchi; Osamu Ohara; Eiichi Ishii; Toshio Heike
Journal:  J Clin Immunol       Date:  2016-11-28       Impact factor: 8.317

Review 4.  Proliferation through activation: hemophagocytic lymphohistiocytosis in hematologic malignancy.

Authors:  Eric J Vick; Kruti Patel; Philippe Prouet; Mike G Martin
Journal:  Blood Adv       Date:  2017-05-09

5.  Interleukin-18 diagnostically distinguishes and pathogenically promotes human and murine macrophage activation syndrome.

Authors:  Eric S Weiss; Charlotte Girard-Guyonvarc'h; Dirk Holzinger; Adriana A de Jesus; Zeshan Tariq; Jennifer Picarsic; Eduardo J Schiffrin; Dirk Foell; Alexei A Grom; Sandra Ammann; Stephan Ehl; Tomoaki Hoshino; Raphaela Goldbach-Mansky; Cem Gabay; Scott W Canna
Journal:  Blood       Date:  2018-01-11       Impact factor: 22.113

Review 6.  Molecular mechanisms in genetically defined autoinflammatory diseases: disorders of amplified danger signaling.

Authors:  Adriana Almeida de Jesus; Scott W Canna; Yin Liu; Raphaela Goldbach-Mansky
Journal:  Annu Rev Immunol       Date:  2015-02-20       Impact factor: 28.527

7.  Interleukin-18 and cytotoxic impairment are independent and synergistic causes of murine virus-induced hyperinflammation.

Authors:  Paul Tsoukas; Emily Rapp; Lauren Van Der Kraak; Eric S Weiss; Vinh Dang; Corinne Schneider; Edwin Klein; Jennifer Picarsic; Rosalba Salcedo; C Andrew Stewart; Scott W Canna
Journal:  Blood       Date:  2020-11-05       Impact factor: 22.113

8.  A xenograft model of macrophage activation syndrome amenable to anti-CD33 and anti-IL-6R treatment.

Authors:  Mark Wunderlich; Courtney Stockman; Mahima Devarajan; Navin Ravishankar; Christina Sexton; Ashish R Kumar; Benjamin Mizukawa; James C Mulloy
Journal:  JCI Insight       Date:  2016-09-22

9.  Weak vaccinia virus-induced NK cell regulation of CD4 T cells is associated with reduced NK cell differentiation and cytolytic activity.

Authors:  Steven D Hatfield; Keith A Daniels; Carey L O'Donnell; Stephen N Waggoner; Raymond M Welsh
Journal:  Virology       Date:  2018-04-30       Impact factor: 3.616

10.  Gene transfer into hematopoietic stem cells reduces HLH manifestations in a murine model of Munc13-4 deficiency.

Authors:  Tayebeh Soheili; Amandine Durand; Fernando E Sepulveda; Julie Rivière; Chantal Lagresle-Peyrou; Hanem Sadek; Geneviève de Saint Basile; Samia Martin; Fulvio Mavilio; Marina Cavazzana; Isabelle André-Schmutz
Journal:  Blood Adv       Date:  2017-12-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.